This article was originally published in The Gray Sheet
Successor for outgoing Chairman, President and CEO Carl Lombardi is being sought by the firm's strategic planning committee; the exec plans to retire in May 2002 after 35 years with the company. The Redmond, Washington patient monitor maker also notes that it has retained investment banking firm Gerard Klauer Mattison to "explore strategic alternatives." Defibrillator firm Cardiac Science dropped a $15-per-share bid for the company in January citing a lack of interest from Spacelabs' board and management. Spacelabs stock closed at $12.39 on the Dec. 13 announcement, up 8.7%...
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.